CYCLOPHARM LIMITED - Announcements

4.52%

$1.04

Market Cap $115.5M

Technology Scientific & Technical Instruments

Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's... Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The Company distributes its products in approximately 65 countries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

CYC	Cyclopharm Secures Maximum US Patent Extension for Technegas	PRICE SENSITIVE	11/06/25	157.57KB	Share
CYC	Technegas US Momentum Accelerates with $US1m Sales Milestone	PRICE SENSITIVE	01/04/25	149.27KB	Share
CYC	Company Update	PRICE SENSITIVE	19/03/25	3.13MB	Share
CYC	CYC signs 5-year Agreement with USA Veterans Administration	PRICE SENSITIVE	14/03/25	127.09KB	Share
CYC	CYC Results Summary	PRICE SENSITIVE	25/02/25	138.61KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	25/02/25	772.48KB	Share
CYC	CYC Signs US National Agreement with HCA for Technegas	PRICE SENSITIVE	23/01/25	104.87KB	Share
CYC	Response to ASX Price Query	PRICE SENSITIVE	06/01/25	699.32KB	Share
CYC	Cyclopharm's USA Technegas Expansion Update	PRICE SENSITIVE	20/12/24	129.51KB	Share
CYC	US Clinical Paper - Technegas for Lung Transplant Evaluation	PRICE SENSITIVE	09/12/24	178.76KB	Share
CYC	First Patients Imaged with Technegas - French Clinical Trial	PRICE SENSITIVE	03/12/24	165.96KB	Share
CYC	CYC Receives First Technegas Orders from US VA Hospitals	PRICE SENSITIVE	27/11/24	100.42KB	Share
CYC	Cyclopharm Bell Potter Healthcare Conference Presentation	PRICE SENSITIVE	19/11/24	4.37MB	Share
CYC	CYC Signs Agreement with VA and First DoD Order Received	PRICE SENSITIVE	03/10/24	104.86KB	Share
CYC	Cyclopharm - 2024 First Half Results & USA Expansion Update	PRICE SENSITIVE	03/09/24	6.72MB	Share
CYC	Cyclopharm 2024 H1 Trading and USA Expansion Update	PRICE SENSITIVE	27/08/24	233.03KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	27/08/24	829.33KB	Share
CYC	Cyclopharm completes oversubscribed Share Purchase Plan	PRICE SENSITIVE	25/06/24	128.01KB	Share
CYC	USA Reimbursement Update for TECHNEGAS	PRICE SENSITIVE	24/06/24	127.77KB	Share
CYC	Cyclopharm Presenting at Macquarie Emerging Leaders Conf	PRICE SENSITIVE	19/06/24	5.48MB	Share
CYC	TECHNEGAS Awarded US Pass-Through Reimbursemt Status	PRICE SENSITIVE	05/06/24	120.99KB	Share
CYC	Cyclopharm Successfully Completes A$20.0 Million Placement	PRICE SENSITIVE	27/05/24	159.13KB	Share
CYC	Cyclopharm Capital Raising	PRICE SENSITIVE	24/05/24	589.46KB	Share
CYC	Cyclopharm Capital Raising Presentation	PRICE SENSITIVE	24/05/24	1.35MB	Share
CYC	Trading Halt	PRICE SENSITIVE	24/05/24	189.29KB	Share
CYC	Cyclopharm Business Update	PRICE SENSITIVE	06/05/24	190.25KB	Share
CYC	First USA Patients Imaged with Technegas	PRICE SENSITIVE	19/03/24	146.37KB	Share
CYC	S&P DJI Announces March 2024 Quarterly Rebalance	PRICE SENSITIVE	01/03/24	120.24KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	28/02/24	613.79KB	Share
CYC	Cyclopharm to Present at Euroz Hartleys Healthcare Forum	PRICE SENSITIVE	06/02/24	3.66MB	Share
CYC	Cyclopharm Trading and USA Launch Update	PRICE SENSITIVE	05/02/24	137.46KB	Share
CYC	Cyclopharm Signs First USA Contract for Technegas	PRICE SENSITIVE	05/12/23	130.72KB	Share
CYC	Cyclopharm Receives USFDA Approval for Technegas	PRICE SENSITIVE	02/10/23	169.57KB	Share
CYC	Investor Presentation Correction	PRICE SENSITIVE	26/09/23	146.19KB	Share
CYC	Investor Presentation Correction	PRICE SENSITIVE	26/09/23	3.07MB	Share
CYC	Cyclopharm Investor Update	PRICE SENSITIVE	26/09/23	3.01MB	Share
CYC	Litigation Update and Receipt of Settlement Payment	PRICE SENSITIVE	25/08/23	149.34KB	Share
CYC	Half Year Accounts	PRICE SENSITIVE	22/08/23	704.25KB	Share
CYC	USFDA Approval Process Update	PRICE SENSITIVE	09/08/23	175.08KB	Share
CYC	Cyclopharm 2023 Half Year Accounts Update - Record Revenues	PRICE SENSITIVE	17/07/23	146.72KB	Share
CYC	Notification of buy-back - CYC	PRICE SENSITIVE	16/05/23	21.97KB	Share
CYC	Cyclopharm Confirms USFDA Scheduled Inspection Date	PRICE SENSITIVE	09/05/23	174.75KB	Share
CYC	USFDA Confirms Technegas Six Month Review Period	PRICE SENSITIVE	24/04/23	176.33KB	Share
CYC	Technegas Enters Final Six Month USFDA Review Cycle	PRICE SENSITIVE	30/03/23	201.56KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	20/02/23	514.93KB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	20/02/23	22.36KB	Share
CYC	Cyclopharm Receives $1.64m R&D Refund	PRICE SENSITIVE	29/11/22	139.2KB	Share
CYC	Half Year 2022 Results	PRICE SENSITIVE	17/08/22	278.97KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	17/08/22	1.43MB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	17/08/22	22.2KB	Share
CYC	Technegas Used In Multicenter COVID Study	PRICE SENSITIVE	07/07/22	176.04KB	Share
CYC	1H 2022 Business Update - Record Revenues	PRICE SENSITIVE	04/07/22	170.6KB	Share
CYC	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
CYC	CYC Results Summary	PRICE SENSITIVE	23/02/22	153.79KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	23/02/22	496.91KB	Share
CYC	Cyclopharm USFDA Update	PRICE SENSITIVE	03/02/22	125.83KB	Share
CYC	Cyclopharm Business Update	PRICE SENSITIVE	24/01/22	175.05KB	Share
CYC	Half Year 2021 Financial Results	PRICE SENSITIVE	23/08/21	169.33KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	23/08/21	1.72MB	Share
CYC	CYC First Half Trading Update	PRICE SENSITIVE	02/07/21	151.3KB	Share
CYC	Cyclopharm USFDA Update	PRICE SENSITIVE	28/06/21	134.25KB	Share
CYC	Managing Director's Address to Shareholders	PRICE SENSITIVE	04/05/21	169.12KB	Share
CYC	CYC 2021 AGM Presentation	PRICE SENSITIVE	04/05/21	2.48MB	Share
CYC	Chairman's Address to Shareholders	PRICE SENSITIVE	04/05/21	146.98KB	Share
CYC	S&P DJI Announces March 2021 Quarterly Rebalance	PRICE SENSITIVE	12/03/21	183.24KB	Share
CYC	Confirmation of Technegas USFDA Timetable	PRICE SENSITIVE	12/03/21	124.93KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	25/02/21	677.08KB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	25/02/21	22.39KB	Share
CYC	Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020	PRICE SENSITIVE	05/02/21	95.5KB	Share
CYC	Cyclopharm Capital Raising Presentation	PRICE SENSITIVE	25/01/21	5.55MB	Share
CYC	Cyclopharm Successfully Completes A$30 Million Placement	PRICE SENSITIVE	25/01/21	165.04KB	Share
CYC	SNMMI Requests USFDA to Expedite Approval For Technegas	PRICE SENSITIVE	22/01/21	551.33KB	Share
CYC	Trading Halt	PRICE SENSITIVE	21/01/21	207.9KB	Share
CYC	USFDA Approval Progress for Technegas and Business Update	PRICE SENSITIVE	14/01/21	121.58KB	Share
CYC	Cyclopharm Investor Presentation	PRICE SENSITIVE	23/09/20	8.7MB	Share
CYC	Technegas USA Trial Successfully Meets Primary Endpoint	PRICE SENSITIVE	15/09/20	196.38KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	25/08/20	1.45MB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	25/08/20	22.24KB	Share
CYC	CYC 1H2020 Business Update	PRICE SENSITIVE	07/07/20	207.85KB	Share
CYC	USFDA Approval to File Received for Technegas	PRICE SENSITIVE	27/05/20	145.55KB	Share
CYC	Technegas Approved in Russia	PRICE SENSITIVE	26/05/20	115.37KB	Share
CYC	USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver	PRICE SENSITIVE	14/04/20	184.04KB	Share
CYC	Cyclopharm Lodges NDA for Technegas with the USFDA	PRICE SENSITIVE	30/03/20	160.24KB	Share
CYC	Cyclopharm Company Update	PRICE SENSITIVE	24/03/20	221KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	26/02/20	529.52KB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	26/02/20	22.41KB	Share
CYC	CYC Institutional Placement - Premium To Share Price	PRICE SENSITIVE	20/12/19	97.15KB	Share
CYC	AGREEMENT TO UTILISE CYCLOTRON FACILITY ASSETS	PRICE SENSITIVE	20/12/19	99.7KB	Share
CYC	Trading Halt	PRICE SENSITIVE	19/12/19	165.95KB	Share
CYC	Pause in Trading	PRICE SENSITIVE	19/12/19	115.7KB	Share
CYC	CYC Business Update	PRICE SENSITIVE	10/12/19	482.92KB	Share
CYC	CYC Half Yearly Reports and Accounts	PRICE SENSITIVE	22/08/19	1.89MB	Share
CYC	Dividend/Distribution - CYC	PRICE SENSITIVE	22/08/19	23.82KB	Share
CYC	Announcement of buy-back - Appendix 3C	PRICE SENSITIVE	21/05/19	266.17KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	27/02/19	888.57KB	Share
CYC	CYC Update - R&D Tax Incentive, USFDA, German Litigation	PRICE SENSITIVE	24/01/19	140.43KB	Share
CYC	CANM Endorses Technegas	PRICE SENSITIVE	19/12/18	241.33KB	Share
CYC	Positive USFDA Meeting - Technegas sales expected in 2019	PRICE SENSITIVE	12/10/18	450.5KB	Share
CYC	CYC Half Yearly Reports and Accounts	PRICE SENSITIVE	23/08/18	1.92MB	Share
CYC	Cyclopharm 2018 First Half Preliminary Headline Update	PRICE SENSITIVE	08/08/18	147.72KB	Share

CYC Cyclopharm Secures Maximum US Patent Extension for Technegas
11/06/25	PRICE SENSITIVE	157.57KB	Share
CYC Technegas US Momentum Accelerates with $US1m Sales Milestone
01/04/25	PRICE SENSITIVE	149.27KB	Share
CYC Company Update
19/03/25	PRICE SENSITIVE	3.13MB	Share
CYC CYC signs 5-year Agreement with USA Veterans Administration
14/03/25	PRICE SENSITIVE	127.09KB	Share
CYC CYC Results Summary
25/02/25	PRICE SENSITIVE	138.61KB	Share
CYC Preliminary Final Report
25/02/25	PRICE SENSITIVE	772.48KB	Share
CYC CYC Signs US National Agreement with HCA for Technegas
23/01/25	PRICE SENSITIVE	104.87KB	Share
CYC Response to ASX Price Query
06/01/25	PRICE SENSITIVE	699.32KB	Share
CYC Cyclopharm's USA Technegas Expansion Update
20/12/24	PRICE SENSITIVE	129.51KB	Share
CYC US Clinical Paper - Technegas for Lung Transplant Evaluation
09/12/24	PRICE SENSITIVE	178.76KB	Share
CYC First Patients Imaged with Technegas - French Clinical Trial
03/12/24	PRICE SENSITIVE	165.96KB	Share
CYC CYC Receives First Technegas Orders from US VA Hospitals
27/11/24	PRICE SENSITIVE	100.42KB	Share
CYC Cyclopharm Bell Potter Healthcare Conference Presentation
19/11/24	PRICE SENSITIVE	4.37MB	Share
CYC CYC Signs Agreement with VA and First DoD Order Received
03/10/24	PRICE SENSITIVE	104.86KB	Share
CYC Cyclopharm - 2024 First Half Results & USA Expansion Update
03/09/24	PRICE SENSITIVE	6.72MB	Share
CYC Cyclopharm 2024 H1 Trading and USA Expansion Update
27/08/24	PRICE SENSITIVE	233.03KB	Share
CYC Half Yearly Report and Accounts
27/08/24	PRICE SENSITIVE	829.33KB	Share
CYC Cyclopharm completes oversubscribed Share Purchase Plan
25/06/24	PRICE SENSITIVE	128.01KB	Share
CYC USA Reimbursement Update for TECHNEGAS
24/06/24	PRICE SENSITIVE	127.77KB	Share
CYC Cyclopharm Presenting at Macquarie Emerging Leaders Conf
19/06/24	PRICE SENSITIVE	5.48MB	Share
CYC TECHNEGAS Awarded US Pass-Through Reimbursemt Status
05/06/24	PRICE SENSITIVE	120.99KB	Share
CYC Cyclopharm Successfully Completes A$20.0 Million Placement
27/05/24	PRICE SENSITIVE	159.13KB	Share
CYC Cyclopharm Capital Raising
24/05/24	PRICE SENSITIVE	589.46KB	Share
CYC Cyclopharm Capital Raising Presentation
24/05/24	PRICE SENSITIVE	1.35MB	Share
CYC Trading Halt
24/05/24	PRICE SENSITIVE	189.29KB	Share
CYC Cyclopharm Business Update
06/05/24	PRICE SENSITIVE	190.25KB	Share
CYC First USA Patients Imaged with Technegas
19/03/24	PRICE SENSITIVE	146.37KB	Share
CYC S&P DJI Announces March 2024 Quarterly Rebalance
01/03/24	PRICE SENSITIVE	120.24KB	Share
CYC Preliminary Final Report
28/02/24	PRICE SENSITIVE	613.79KB	Share
CYC Cyclopharm to Present at Euroz Hartleys Healthcare Forum
06/02/24	PRICE SENSITIVE	3.66MB	Share
CYC Cyclopharm Trading and USA Launch Update
05/02/24	PRICE SENSITIVE	137.46KB	Share
CYC Cyclopharm Signs First USA Contract for Technegas
05/12/23	PRICE SENSITIVE	130.72KB	Share
CYC Cyclopharm Receives USFDA Approval for Technegas
02/10/23	PRICE SENSITIVE	169.57KB	Share
CYC Investor Presentation Correction
26/09/23	PRICE SENSITIVE	146.19KB	Share
CYC Investor Presentation Correction
26/09/23	PRICE SENSITIVE	3.07MB	Share
CYC Cyclopharm Investor Update
26/09/23	PRICE SENSITIVE	3.01MB	Share
CYC Litigation Update and Receipt of Settlement Payment
25/08/23	PRICE SENSITIVE	149.34KB	Share
CYC Half Year Accounts
22/08/23	PRICE SENSITIVE	704.25KB	Share
CYC USFDA Approval Process Update
09/08/23	PRICE SENSITIVE	175.08KB	Share
CYC Cyclopharm 2023 Half Year Accounts Update - Record Revenues
17/07/23	PRICE SENSITIVE	146.72KB	Share
CYC Notification of buy-back - CYC
16/05/23	PRICE SENSITIVE	21.97KB	Share
CYC Cyclopharm Confirms USFDA Scheduled Inspection Date
09/05/23	PRICE SENSITIVE	174.75KB	Share
CYC USFDA Confirms Technegas Six Month Review Period
24/04/23	PRICE SENSITIVE	176.33KB	Share
CYC Technegas Enters Final Six Month USFDA Review Cycle
30/03/23	PRICE SENSITIVE	201.56KB	Share
CYC Preliminary Final Report
20/02/23	PRICE SENSITIVE	514.93KB	Share
CYC Dividend/Distribution - CYC
20/02/23	PRICE SENSITIVE	22.36KB	Share
CYC Cyclopharm Receives $1.64m R&D Refund
29/11/22	PRICE SENSITIVE	139.2KB	Share
CYC Half Year 2022 Results
17/08/22	PRICE SENSITIVE	278.97KB	Share
CYC Half Yearly Report and Accounts
17/08/22	PRICE SENSITIVE	1.43MB	Share
CYC Dividend/Distribution - CYC
17/08/22	PRICE SENSITIVE	22.2KB	Share
CYC Technegas Used In Multicenter COVID Study
07/07/22	PRICE SENSITIVE	176.04KB	Share
CYC 1H 2022 Business Update - Record Revenues
04/07/22	PRICE SENSITIVE	170.6KB	Share
CYC S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
CYC CYC Results Summary
23/02/22	PRICE SENSITIVE	153.79KB	Share
CYC Preliminary Final Report
23/02/22	PRICE SENSITIVE	496.91KB	Share
CYC Cyclopharm USFDA Update
03/02/22	PRICE SENSITIVE	125.83KB	Share
CYC Cyclopharm Business Update
24/01/22	PRICE SENSITIVE	175.05KB	Share
CYC Half Year 2021 Financial Results
23/08/21	PRICE SENSITIVE	169.33KB	Share
CYC Half Yearly Report and Accounts
23/08/21	PRICE SENSITIVE	1.72MB	Share
CYC CYC First Half Trading Update
02/07/21	PRICE SENSITIVE	151.3KB	Share
CYC Cyclopharm USFDA Update
28/06/21	PRICE SENSITIVE	134.25KB	Share
CYC Managing Director's Address to Shareholders
04/05/21	PRICE SENSITIVE	169.12KB	Share
CYC CYC 2021 AGM Presentation
04/05/21	PRICE SENSITIVE	2.48MB	Share
CYC Chairman's Address to Shareholders
04/05/21	PRICE SENSITIVE	146.98KB	Share
CYC S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21	PRICE SENSITIVE	183.24KB	Share
CYC Confirmation of Technegas USFDA Timetable
12/03/21	PRICE SENSITIVE	124.93KB	Share
CYC Preliminary Final Report
25/02/21	PRICE SENSITIVE	677.08KB	Share
CYC Dividend/Distribution - CYC
25/02/21	PRICE SENSITIVE	22.39KB	Share
CYC Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020
05/02/21	PRICE SENSITIVE	95.5KB	Share
CYC Cyclopharm Capital Raising Presentation
25/01/21	PRICE SENSITIVE	5.55MB	Share
CYC Cyclopharm Successfully Completes A$30 Million Placement
25/01/21	PRICE SENSITIVE	165.04KB	Share
CYC SNMMI Requests USFDA to Expedite Approval For Technegas
22/01/21	PRICE SENSITIVE	551.33KB	Share
CYC Trading Halt
21/01/21	PRICE SENSITIVE	207.9KB	Share
CYC USFDA Approval Progress for Technegas and Business Update
14/01/21	PRICE SENSITIVE	121.58KB	Share
CYC Cyclopharm Investor Presentation
23/09/20	PRICE SENSITIVE	8.7MB	Share
CYC Technegas USA Trial Successfully Meets Primary Endpoint
15/09/20	PRICE SENSITIVE	196.38KB	Share
CYC Half Yearly Report and Accounts
25/08/20	PRICE SENSITIVE	1.45MB	Share
CYC Dividend/Distribution - CYC
25/08/20	PRICE SENSITIVE	22.24KB	Share
CYC CYC 1H2020 Business Update
07/07/20	PRICE SENSITIVE	207.85KB	Share
CYC USFDA Approval to File Received for Technegas
27/05/20	PRICE SENSITIVE	145.55KB	Share
CYC Technegas Approved in Russia
26/05/20	PRICE SENSITIVE	115.37KB	Share
CYC USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver
14/04/20	PRICE SENSITIVE	184.04KB	Share
CYC Cyclopharm Lodges NDA for Technegas with the USFDA
30/03/20	PRICE SENSITIVE	160.24KB	Share
CYC Cyclopharm Company Update
24/03/20	PRICE SENSITIVE	221KB	Share
CYC Preliminary Final Report
26/02/20	PRICE SENSITIVE	529.52KB	Share
CYC Dividend/Distribution - CYC
26/02/20	PRICE SENSITIVE	22.41KB	Share
CYC CYC Institutional Placement - Premium To Share Price
20/12/19	PRICE SENSITIVE	97.15KB	Share
CYC AGREEMENT TO UTILISE CYCLOTRON FACILITY ASSETS
20/12/19	PRICE SENSITIVE	99.7KB	Share
CYC Trading Halt
19/12/19	PRICE SENSITIVE	165.95KB	Share
CYC Pause in Trading
19/12/19	PRICE SENSITIVE	115.7KB	Share
CYC CYC Business Update
10/12/19	PRICE SENSITIVE	482.92KB	Share
CYC CYC Half Yearly Reports and Accounts
22/08/19	PRICE SENSITIVE	1.89MB	Share
CYC Dividend/Distribution - CYC
22/08/19	PRICE SENSITIVE	23.82KB	Share
CYC Announcement of buy-back - Appendix 3C
21/05/19	PRICE SENSITIVE	266.17KB	Share
CYC Preliminary Final Report
27/02/19	PRICE SENSITIVE	888.57KB	Share
CYC CYC Update - R&D Tax Incentive, USFDA, German Litigation
24/01/19	PRICE SENSITIVE	140.43KB	Share
CYC CANM Endorses Technegas
19/12/18	PRICE SENSITIVE	241.33KB	Share
CYC Positive USFDA Meeting - Technegas sales expected in 2019
12/10/18	PRICE SENSITIVE	450.5KB	Share
CYC CYC Half Yearly Reports and Accounts
23/08/18	PRICE SENSITIVE	1.92MB	Share
CYC Cyclopharm 2018 First Half Preliminary Headline Update
08/08/18	PRICE SENSITIVE	147.72KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.04		Change 0.045(4.52%)		Mkt cap ! $115.5M

Open	High	Low	Value	Volume
$1.02	$1.06	$1.00	$35.35K	34.22K

Buyers (Bids)

No.	Vol.	Price($)
1	658	$1.03

Sellers (Offers)

Price($)	Vol.	No.
$1.04	2683	2

View Market Depth

No.	Vol.	Price($)
1	658	1.030
2	10999	1.010
5	32218	1.000
2	997	0.990
2	7200	0.980

Price($)	Vol.	No.
1.040	2683	2
1.060	940	1
1.075	410	1
1.085	275	1
1.100	12250	1

Last trade - 16.10pm 31/07/2025 (20 minute delay)


Last $1.03		Change 0.045 ( 2.67 %)
Open	High	Low	Volume
$1.00	$1.05	$1.00	7738
Last updated 15.59pm 31/07/2025 ?

CYC (ASX) Chart

CYCLOPHARM LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

CYCLOPHARM LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Corporate Spotlight
Not Yet Available